Your session is about to expire
← Back to Search
Corticosteroid
Methylprednisolone Tablet for Finger sprain
Phase 2 & 3
Waitlist Available
Led By Brian Katt, MD
Research Sponsored by Robert Wood Johnson Barnabas Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial
Awards & highlights
All Individual Drugs Already Approved
No Placebo-Only Group
Approved for 50 Other Conditions
Summary
This trial is testing if steroids can help people with hand injuries that don't need surgery by reducing inflammation. The goal is to see if this treatment improves their ability to move and use their hands.
Eligible Conditions
- Finger sprain
- Hand Injuries
- Finger Injuries
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
MCP, DIP, PIP of digits 2-5: Extension
MCP, DIP, PIP of digits 2-5: Flexion
MCP, DIP, PIP of digits 2-5: abduction
+11 moreSecondary study objectives
Complications
Edema Measurements
VAS Pain Scale
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Approved for 50 Other Conditions
This treatment demonstrated efficacy for 50 other conditions.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Steroid GroupExperimental Treatment1 Intervention
Patients receive 21 tablets of 4 mg methylprednisolone to be taken by mouth over a 6 week taper. Patients will be advised to not take other anti-inflammatory medications like NSAIDs.
Group II: Control GroupActive Control1 Intervention
Patients will recieve standard treatment that focuses on mobilization and stabilization using common techniques like buddy taping and splinting. Pain control will be managed using non-NSAID medications like Tylenol or opioid narcotics when deemed medically necessary.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Methylprednisolone
FDA approved
Find a Location
Who is running the clinical trial?
Robert Wood Johnson Barnabas HealthLead Sponsor
1 Previous Clinical Trials
32 Total Patients Enrolled
Brielle OrthopedicsUNKNOWN
1 Previous Clinical Trials
32 Total Patients Enrolled
University Orthopedics AssociatesUNKNOWN
Share this study with friends
Copy Link
Messenger